Intelligent Investor

McMillan Shakespeare wrap-up

By · 9 Sep 2013
By ·
9 Sep 2013 · 2 min read
Upsell Banner

Recommendation

McMillan Shakespeare Limited - MMS
Current price
$19.33 at 12:50 (19 April 2024)

Price at review
$12.99 at (09 September 2013)

Business Risk
Very High

Share Price Risk
Very High
All Prices are in AUD ($)

It’s a standing joke that any time a stock falls for no obvious reason the newspapers label it ‘profit taking’, but it’s hard to see today’s 3% fall in McMillan Shakespeare as anything else.

As we wrote in How to back Rudd and McMillan on 6 Aug 13 (Avoid – $9.07), McMillan had much to lose under Labor and much to gain under the Coalition. But it had already put in the hard yards as the odds on Tony Abbott firmed over the past few weeks, gaining 43% to Friday’s close.

We closed off that article by warning that ‘we wouldn’t recommend being invested in McMillan Shakespeare for long’, so we'd be in full agreement with anyone bagging their profit and heading for the exits.

Of course, as part of that hedged strategy, we also suggested backing Labor at the then odds of 2.4-1, and you’d have lost on that. But all up you’d have turned the $1,000 investment in McMillan into $1,432, leaving a profit of about $230, or about 19%, before brokerage and taxes, after allowing for the $200 lost on the bet.

We expect McMillan to earn around 80 cents per share this year now the Fringe Benefits Tax will remain unchanged, putting the company on a forecast price-earnings ratio of 16. However, while McMillan has escaped unscathed this time, its vulnerability to policy change remains. AVOID.

IMPORTANT: Intelligent Investor is published by InvestSMART Financial Services Pty Limited AFSL 226435 (Licensee). Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. InvestSMART Funds Management Limited (RE) is the responsible entity of various managed investment schemes and is a related party of the Licensee. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article. Any such transaction could affect the price of the share. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.
Share this article and show your support

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here